化合物 AChE/BChE/BACE-1-IN-1 T61206

Product Introduction
Bioactivity


英文名: AChE/BChE/BACE-1-IN-1

描述: AChE/BChE/BACE-1-IN-1 (Compound 4k) is an orally active inhibitor that targets acetylcholinesterase (AChE), butyrylcholinesterase (BChE), and β-site amyloid precursor protein cleaving enzyme 1 (BACE-1). It displays IC50 values of 0.058 μM, 0.082 μM, and 0.115 μM against hAChE, hBChE, and hBACE-1, respectively. AChE/BChE/BACE-1-IN-1 exhibits significant binding affinity with PAS-AChE, excellent ability to cross the blood-brain barrier, potential disassembly of amyloid-beta (Aβ) aggregates, and neuroprotective properties against Aβ-induced stress. Moreover, AChE/BChE/BACE-1-IN-1 demonstrates remarkable antioxidant capabilities [1].

体内活性: AChE/BChE/BACE-1-IN-1 (Compound 4k) (0-10 mg/kg; p.o.) ameliorates cognitive dysfunction against the scopolamine-induced amnesia model in the Y-maze test [1].

存储条件: Powder: -20°C for 3 years | In solvent: -80°C for 1 year

化合物 AChE/BChE/BACE-1-IN-1 T61206信息由TargetMol中国为您提供，如您想了解更多关于化合物 AChE/BChE/BACE-1-IN-1 T61206报价、型号、参数等信息，欢迎来电或留言咨询。

注：该产品未在中华人民共和国食品药品监督管理部门申请医疗器械注册和备案，不可用于临床诊断或治疗等相关用途